nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP1A2—chronic obstructive pulmonary disease	0.242	0.634	CbGaD
Estropipate—ALB—chronic obstructive pulmonary disease	0.14	0.366	CbGaD
Estropipate—Exemestane—Prednisone—chronic obstructive pulmonary disease	0.122	0.506	CrCrCtD
Estropipate—Exemestane—Prednisolone—chronic obstructive pulmonary disease	0.119	0.494	CrCrCtD
Estropipate—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0315	0.139	CbGbCtD
Estropipate—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0315	0.139	CbGbCtD
Estropipate—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0298	0.131	CbGbCtD
Estropipate—ALB—Prednisone—chronic obstructive pulmonary disease	0.0246	0.108	CbGbCtD
Estropipate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0242	0.106	CbGbCtD
Estropipate—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0239	0.105	CbGbCtD
Estropipate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0163	0.0719	CbGbCtD
Estropipate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0156	0.0686	CbGbCtD
Estropipate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0139	0.0612	CbGbCtD
Estropipate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00815	0.0359	CbGbCtD
Estropipate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0077	0.0339	CbGbCtD
Estropipate—Estrone—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.185	CrCbGaD
Estropipate—Conjugated Estrogens—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.179	CrCbGaD
Estropipate—Estrone—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.179	CrCbGaD
Estropipate—Estradiol—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.14	CrCbGaD
Estropipate—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000192	0.0016	CcSEcCtD
Estropipate—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.0016	CcSEcCtD
Estropipate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00158	CcSEcCtD
Estropipate—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00158	CcSEcCtD
Estropipate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00157	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00156	CcSEcCtD
Estropipate—Estradiol—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.135	CrCbGaD
Estropipate—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00156	CcSEcCtD
Estropipate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Estropipate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Estropipate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Estropipate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Estropipate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00154	CcSEcCtD
Estropipate—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00154	CcSEcCtD
Estropipate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00152	CcSEcCtD
Estropipate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00151	CcSEcCtD
Estropipate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000181	0.0015	CcSEcCtD
Estropipate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.0015	CcSEcCtD
Estropipate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00149	CcSEcCtD
Estropipate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00148	CcSEcCtD
Estropipate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00148	CcSEcCtD
Estropipate—Cough—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00148	CcSEcCtD
Estropipate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Estropipate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Estropipate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00146	CcSEcCtD
Estropipate—Cough—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Estropipate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Estropipate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00145	CcSEcCtD
Estropipate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00145	CcSEcCtD
Estropipate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Estropipate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Estropipate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Estropipate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Estropipate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Estropipate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Estropipate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Estropipate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Estropipate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Estropipate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00142	CcSEcCtD
Estropipate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Estropipate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Estropipate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00141	CcSEcCtD
Estropipate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.0014	CcSEcCtD
Estropipate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.0014	CcSEcCtD
Estropipate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Estropipate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Estropipate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Estropipate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Estropipate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00138	CcSEcCtD
Estropipate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00138	CcSEcCtD
Estropipate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Estropipate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000163	0.00136	CcSEcCtD
Estropipate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00136	CcSEcCtD
Estropipate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00136	CcSEcCtD
Estropipate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00135	CcSEcCtD
Estropipate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00135	CcSEcCtD
Estropipate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00135	CcSEcCtD
Estropipate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00134	CcSEcCtD
Estropipate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00133	CcSEcCtD
Estropipate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00133	CcSEcCtD
Estropipate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00132	CcSEcCtD
Estropipate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00131	CcSEcCtD
Estropipate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00131	CcSEcCtD
Estropipate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.0013	CcSEcCtD
Estropipate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00129	CcSEcCtD
Estropipate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00129	CcSEcCtD
Estropipate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00128	CcSEcCtD
Estropipate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00128	CcSEcCtD
Estropipate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00127	CcSEcCtD
Estropipate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Estropipate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00125	CcSEcCtD
Estropipate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00125	CcSEcCtD
Estropipate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00124	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00124	CcSEcCtD
Estropipate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00123	CcSEcCtD
Estropipate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00123	CcSEcCtD
Estropipate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00123	CcSEcCtD
Estropipate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Estropipate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Estropipate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Estropipate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00121	CcSEcCtD
Estropipate—Injury—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00121	CcSEcCtD
Estropipate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00121	CcSEcCtD
Estropipate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Estropipate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Estropipate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000144	0.0012	CcSEcCtD
Estropipate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.0012	CcSEcCtD
Estropipate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00119	CcSEcCtD
Estropipate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00119	CcSEcCtD
Estropipate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00119	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00119	CcSEcCtD
Estropipate—Estrone—ALB—chronic obstructive pulmonary disease	0.000143	0.103	CrCbGaD
Estropipate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Estropipate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Estropipate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Estropipate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Estropipate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00118	CcSEcCtD
Estropipate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Estropipate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Estropipate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Estropipate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00116	CcSEcCtD
Estropipate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00116	CcSEcCtD
Estropipate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00116	CcSEcCtD
Estropipate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00116	CcSEcCtD
Estropipate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Estropipate—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Estropipate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Estropipate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Estropipate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.00115	CcSEcCtD
Estropipate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.00115	CcSEcCtD
Estropipate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.00114	CcSEcCtD
Estropipate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Estropipate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00113	CcSEcCtD
Estropipate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00113	CcSEcCtD
Estropipate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00113	CcSEcCtD
Estropipate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00113	CcSEcCtD
Estropipate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Estropipate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Estropipate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00111	CcSEcCtD
Estropipate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000132	0.0011	CcSEcCtD
Estropipate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.0011	CcSEcCtD
Estropipate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Estropipate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Estropipate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Estropipate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Estropipate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.00109	CcSEcCtD
Estropipate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Estropipate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Estropipate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Estropipate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Estropipate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Estropipate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Estropipate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Estropipate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Estropipate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00106	CcSEcCtD
Estropipate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00105	CcSEcCtD
Estropipate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00104	CcSEcCtD
Estropipate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00103	CcSEcCtD
Estropipate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00103	CcSEcCtD
Estropipate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Estropipate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Estropipate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Estropipate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00102	CcSEcCtD
Estropipate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000999	CcSEcCtD
Estropipate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000994	CcSEcCtD
Estropipate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000994	CcSEcCtD
Estropipate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00098	CcSEcCtD
Estropipate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00098	CcSEcCtD
Estropipate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000973	CcSEcCtD
Estropipate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000965	CcSEcCtD
Estropipate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000963	CcSEcCtD
Estropipate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00096	CcSEcCtD
Estropipate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000948	CcSEcCtD
Estropipate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000948	CcSEcCtD
Estropipate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00094	CcSEcCtD
Estropipate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000938	CcSEcCtD
Estropipate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000928	CcSEcCtD
Estropipate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000925	CcSEcCtD
Estropipate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000919	CcSEcCtD
Estropipate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000916	CcSEcCtD
Estropipate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000916	CcSEcCtD
Estropipate—Estradiol—ALB—chronic obstructive pulmonary disease	0.000109	0.0782	CrCbGaD
Estropipate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000897	CcSEcCtD
Estropipate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000895	CcSEcCtD
Estropipate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00088	CcSEcCtD
Estropipate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00088	CcSEcCtD
Estropipate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000873	CcSEcCtD
Estropipate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000873	CcSEcCtD
Estropipate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000872	CcSEcCtD
Estropipate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000872	CcSEcCtD
Estropipate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000872	CcSEcCtD
Estropipate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000868	CcSEcCtD
Estropipate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000868	CcSEcCtD
Estropipate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000865	CcSEcCtD
Estropipate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000865	CcSEcCtD
Estropipate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000862	CcSEcCtD
Estropipate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000855	CcSEcCtD
Estropipate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000854	CcSEcCtD
Estropipate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000852	CcSEcCtD
Estropipate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00085	CcSEcCtD
Estropipate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000842	CcSEcCtD
Estropipate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00084	CcSEcCtD
Estropipate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000838	CcSEcCtD
Estropipate—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000838	CcSEcCtD
Estropipate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000831	CcSEcCtD
Estropipate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.94e-05	0.000826	CcSEcCtD
Estropipate—Rash—Salbutamol—chronic obstructive pulmonary disease	9.93e-05	0.000824	CcSEcCtD
Estropipate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.92e-05	0.000824	CcSEcCtD
Estropipate—Nausea—Formoterol—chronic obstructive pulmonary disease	9.9e-05	0.000823	CcSEcCtD
Estropipate—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.9e-05	0.000823	CcSEcCtD
Estropipate—Headache—Salbutamol—chronic obstructive pulmonary disease	9.86e-05	0.000819	CcSEcCtD
Estropipate—Nausea—Montelukast—chronic obstructive pulmonary disease	9.7e-05	0.000806	CcSEcCtD
Estropipate—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.35e-05	0.000777	CcSEcCtD
Estropipate—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.00075	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.00075	CcSEcCtD
Estropipate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000717	CcSEcCtD
Estropipate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.38e-05	0.000696	CcSEcCtD
Estropipate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000693	CcSEcCtD
Estropipate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.17e-05	0.000678	CcSEcCtD
Estropipate—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000678	CcSEcCtD
Estropipate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.11e-05	0.000673	CcSEcCtD
Estropipate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000672	CcSEcCtD
Estropipate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000668	CcSEcCtD
Estropipate—Erythema—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000668	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	7.82e-05	0.00268	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	7.81e-05	0.00268	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	7.76e-05	0.00266	CbGpPWpGaD
Estropipate—Pain—Prednisolone—chronic obstructive pulmonary disease	7.72e-05	0.000641	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	7.69e-05	0.00263	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.65e-05	0.00262	CbGpPWpGaD
Estropipate—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.5e-05	0.00257	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	7.5e-05	0.00257	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	7.5e-05	0.00257	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.49e-05	0.00256	CbGpPWpGaD
Estropipate—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	7.39e-05	0.00253	CbGpPWpGaD
Estropipate—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.00061	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.34e-05	0.00251	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	7.32e-05	0.00251	CbGpPWpGaD
Estropipate—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	7.31e-05	0.0025	CbGpPWpGaD
Estropipate—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.0006	CcSEcCtD
Estropipate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000596	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.13e-05	0.00244	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	7.13e-05	0.00244	CbGpPWpGaD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.00243	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	7.02e-05	0.0024	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.01e-05	0.0024	CbGpPWpGaD
Estropipate—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7e-05	0.0024	CbGpPWpGaD
Estropipate—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000569	CcSEcCtD
Estropipate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000569	CcSEcCtD
Estropipate—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000567	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000565	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	6.73e-05	0.0023	CbGpPWpGaD
Estropipate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.65e-05	0.000553	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	6.65e-05	0.00228	CbGpPWpGaD
Estropipate—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	6.63e-05	0.00227	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	6.62e-05	0.00227	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	6.62e-05	0.00227	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.59e-05	0.00226	CbGpPWpGaD
Estropipate—Oedema—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000545	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000545	CcSEcCtD
Estropipate—Infection—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000541	CcSEcCtD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.44e-05	0.00221	CbGpPWpGaD
Estropipate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000534	CcSEcCtD
Estropipate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000529	CcSEcCtD
Estropipate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00218	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.21e-05	0.00213	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	6.15e-05	0.00211	CbGpPWpGaD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.06e-05	0.00208	CbGpPWpGaD
Estropipate—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.99e-05	0.00205	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000497	CcSEcCtD
Estropipate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.97e-05	0.000496	CcSEcCtD
Estropipate—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.94e-05	0.000493	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000489	CcSEcCtD
Estropipate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.79e-05	0.00198	CbGpPWpGaD
Estropipate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.00048	CcSEcCtD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.75e-05	0.00197	CbGpPWpGaD
Estropipate—Rash—Prednisolone—chronic obstructive pulmonary disease	5.69e-05	0.000473	CcSEcCtD
Estropipate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.69e-05	0.000472	CcSEcCtD
Estropipate—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	5.66e-05	0.00194	CbGpPWpGaD
Estropipate—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.00047	CcSEcCtD
Estropipate—Headache—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.00047	CcSEcCtD
Estropipate—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	5.61e-05	0.00192	CbGpPWpGaD
Estropipate—Constipation—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000466	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	5.59e-05	0.00191	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	5.48e-05	0.00188	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	5.47e-05	0.00187	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	5.47e-05	0.00187	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	5.46e-05	0.00187	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	5.46e-05	0.00187	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000446	CcSEcCtD
Estropipate—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.36e-05	0.000445	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.32e-05	0.00182	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.28e-05	0.00181	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.22e-05	0.00179	CbGpPWpGaD
Estropipate—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000433	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000431	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000431	CcSEcCtD
Estropipate—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.12e-05	0.00176	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.06e-05	0.00173	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5e-05	0.00171	CbGpPWpGaD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.92e-05	0.00168	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	4.91e-05	0.00168	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.85e-05	0.00166	CbGpPWpGaD
Estropipate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000402	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.75e-05	0.00163	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	4.74e-05	0.00162	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	4.72e-05	0.00162	CbGpPWpGaD
Estropipate—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.00161	CbGpPWpGaD
Estropipate—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.000391	CcSEcCtD
Estropipate—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	4.69e-05	0.00161	CbGpPWpGaD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.0016	CbGpPWpGaD
Estropipate—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000386	CcSEcCtD
Estropipate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.00158	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.55e-05	0.00156	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.53e-05	0.00155	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	4.49e-05	0.00154	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.49e-05	0.00154	CbGpPWpGaD
Estropipate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000373	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.47e-05	0.00153	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.45e-05	0.00152	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.35e-05	0.00149	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.35e-05	0.00149	CbGpPWpGaD
Estropipate—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.34e-05	0.00036	CcSEcCtD
Estropipate—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.33e-05	0.00148	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.3e-05	0.00147	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.28e-05	0.00146	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.22e-05	0.00145	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.21e-05	0.00144	CbGpPWpGaD
Estropipate—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000347	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.15e-05	0.00142	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.15e-05	0.00142	CbGpPWpGaD
Estropipate—Rash—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.000344	CcSEcCtD
Estropipate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000343	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	4.11e-05	0.00141	CbGpPWpGaD
Estropipate—Headache—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000341	CcSEcCtD
Estropipate—ESR2—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.03e-05	0.00138	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.99e-05	0.00137	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	3.96e-05	0.00136	CbGpPWpGaD
Estropipate—Nausea—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000324	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.81e-05	0.00131	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.79e-05	0.0013	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.75e-05	0.00129	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.56e-05	0.00122	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.53e-05	0.00121	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.51e-05	0.0012	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.51e-05	0.0012	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.00119	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.34e-05	0.00114	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.3e-05	0.00113	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.23e-05	0.00111	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.23e-05	0.0011	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.23e-05	0.0011	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.22e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.0011	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.2e-05	0.0011	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.00109	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.16e-05	0.00108	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.16e-05	0.00108	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.07e-05	0.00105	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.06e-05	0.00105	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.04e-05	0.00104	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.00103	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.01e-05	0.00103	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.01e-05	0.00103	CbGpPWpGaD
Estropipate—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.00103	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3e-05	0.00103	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.97e-05	0.00102	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.96e-05	0.00101	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.96e-05	0.00101	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	2.89e-05	0.000991	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000991	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	2.88e-05	0.000986	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.84e-05	0.000974	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.82e-05	0.000966	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.82e-05	0.000966	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.77e-05	0.00095	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.000944	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.75e-05	0.000944	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.74e-05	0.000937	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.73e-05	0.000934	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.72e-05	0.000931	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.69e-05	0.000922	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.66e-05	0.000912	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.61e-05	0.000895	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000892	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000882	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.56e-05	0.000878	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.46e-05	0.000842	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.44e-05	0.000837	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.44e-05	0.000837	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.43e-05	0.000832	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.4e-05	0.000821	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.31e-05	0.000793	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.31e-05	0.00079	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.28e-05	0.000782	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.28e-05	0.000782	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2.21e-05	0.000758	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.19e-05	0.000751	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000734	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.13e-05	0.000728	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.1e-05	0.00072	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.1e-05	0.000718	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.09e-05	0.000715	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.08e-05	0.000713	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.07e-05	0.000708	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000696	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.00069	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.01e-05	0.000689	CbGpPWpGaD
Estropipate—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000682	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.000681	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.98e-05	0.000677	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000676	CbGpPWpGaD
Estropipate—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000663	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.92e-05	0.000659	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.89e-05	0.000648	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.84e-05	0.000629	CbGpPWpGaD
Estropipate—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000616	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.75e-05	0.000601	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.000577	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.000558	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.62e-05	0.000555	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.62e-05	0.000553	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000543	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.58e-05	0.000542	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.56e-05	0.000535	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.54e-05	0.000529	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000513	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000505	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000491	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.43e-05	0.00049	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000488	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.41e-05	0.000484	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.000477	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.39e-05	0.000475	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000475	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	0.000464	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.00045	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.31e-05	0.00045	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.27e-05	0.000436	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.000431	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.000422	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000402	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.14e-05	0.000392	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	0.000375	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.08e-05	0.00037	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000368	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.07e-05	0.000367	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000362	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.06e-05	0.000362	CbGpPWpGaD
Estropipate—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000358	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000358	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000351	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.000345	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000344	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.71e-06	0.000333	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.55e-06	0.000327	CbGpPWpGaD
Estropipate—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	9.54e-06	0.000327	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.44e-06	0.000323	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	9.26e-06	0.000317	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.79e-06	0.000301	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.66e-06	0.000297	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.58e-06	0.000294	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.56e-06	0.000293	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.25e-06	0.000283	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.98e-06	0.000273	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.81e-06	0.000267	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.67e-06	0.000263	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.4e-06	0.000253	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.38e-06	0.000253	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.33e-06	0.000251	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.31e-06	0.00025	CbGpPWpGaD
Estropipate—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.23e-06	0.000248	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.19e-06	0.000246	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.82e-06	0.000234	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.77e-06	0.000232	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.74e-06	0.000231	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.67e-06	0.000229	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	6.49e-06	0.000222	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.39e-06	0.000219	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.21e-06	0.000213	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.02e-06	0.000206	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6e-06	0.000206	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.92e-06	0.000203	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.75e-06	0.000197	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.71e-06	0.000196	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.64e-06	0.000193	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.57e-06	0.000191	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.51e-06	0.000189	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-06	0.000179	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.15e-06	0.000176	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.13e-06	0.000176	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.1e-06	0.000175	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.06e-06	0.000173	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.74e-06	0.000163	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.71e-06	0.000161	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.61e-06	0.000158	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.47e-06	0.000153	CbGpPWpGaD
Estropipate—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.15e-06	0.000142	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.14e-06	0.000142	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.96e-06	0.000136	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.9e-06	0.000134	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.8e-06	0.00013	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.73e-06	0.000128	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.64e-06	0.000125	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-06	0.000122	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.45e-06	0.000118	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-06	0.000116	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.13e-06	0.000107	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.04e-06	0.000104	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	9.95e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.86e-06	9.81e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-06	8.03e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-06	7.68e-05	CbGpPWpGaD
